JetBlue warns of a possible 3Q loss as it ends a deal with American and faces flight disruptions
JetBlue shares are losing altitude as the airline warns that third-quarter and full-year results will be worse than it had previously expected
1970-01-01 08:00
Building Industry Association and Brookfield Residential Kick Off Second Junior Builder Camp in Costa Mesa
IRVINE, Calif.--(BUSINESS WIRE)--Aug 1, 2023--
1970-01-01 08:00
Semtech and Kairos Implement Leak Detection Systems to Preserve Historic Ghirardelli Square Building
CAMARILLO, Calif.--(BUSINESS WIRE)--Aug 1, 2023--
1970-01-01 08:00
Airbus Ventures Announces New Investment in Impulse Space
MENLO PARK, Calif.--(BUSINESS WIRE)--Aug 1, 2023--
1970-01-01 08:00
Mars completes acquisition of nutritious meal company Kevin’s Natural Foods
McLEAN, Va.--(BUSINESS WIRE)--Aug 1, 2023--
1970-01-01 08:00
WWE® Returns to India This September With WWE Superstar Spectacle
STAMFORD, Conn.--(BUSINESS WIRE)--Aug 1, 2023--
1970-01-01 08:00
Ford restarts electric pickup truck factory after retooling to increase output, says orders are up
Ford is resuming production of the F-150 Lightning electric pickup after closing a factory in Dearborn, Michigan, for six weeks to triple production capacity
1970-01-01 08:00
Job openings fall to lowest level in 2 years as demand for workers cools
U.S. employers posted fewer jobs in June, a sign that the red-hot demand for workers that has been a key feature of the post-pandemic economy is cooling a bit
1970-01-01 08:00
US construction spending rises strongly in June
WASHINGTON U.S. construction spending increased solidly in June and the prior month's data was revised higher, boosted by
1970-01-01 08:00
Barrell Craft Spirits® Introduces Bourbon Batch 035 and Rye Batch 004
LOUISVILLE, Ky.--(BUSINESS WIRE)--Aug 1, 2023--
1970-01-01 08:00
Get Ready to Savor the Flavors of the Season with The Fresh Market's Fall-Inspired Offerings
GREENSBORO, N.C.--(BUSINESS WIRE)--Aug 1, 2023--
1970-01-01 08:00
AVM Biotechnology Announces Twenty-Eight (28) Solid Tumor and Blood Cancer Patients have been Treated with Immunomodulatory AVM0703 through Expanded Access/Compassionate Use Programs
SEATTLE--(BUSINESS WIRE)--Aug 1, 2023--
1970-01-01 08:00